IMMUNOGENE ZUSAMMENSETZUNGEN

Patent europeic · EP3310381 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3310381
Numer da la dumonda
EP16732999
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
15-06-2016
Publitgà
25-04-2018
Concedì
07-06-2023
Stritgà
25-01-2024
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 39/112 (2006.01)
A61K 39/00 (2006.01)
A61P 31/04 (2006.01)
A61P 37/02 (2006.01)
Prioritad
EP 15020097 16.06.2015
Dumonda PCT
PCT/EP2016/063776 15.06.2016
Publicaziun PCT
WO2016/202872 22.12.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-04-2024

    Midada

    Published in Swissreg on 24.04.2024

  2. 17-04-2024

    Midada

    Published in Swissreg on 17.04.2024

  3. 25-01-2024

    Stritgà, taxa betg pajada

    Published in Swissreg on 25.01.2024

  4. 07-06-2023

    Concedì

    Published in Swissreg on 07.06.2023

Partidas

Possessur

GlaxoSmithKline Biologicals SA

Rue de l'Institut 89, 1330 Rixensart, BE

Inventur

GERKE, Christiane

53100 Siena, IT

SAUL, Allan James

53100 Siena, IT

MARTIN, Laura Bartle

53100 Siena, IT

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.